Patients with STAT3 mutations had a higher frequency of anemia (p = 0.046), neutropenia (p = 0.005), higher LGL counts (p = 0.039), raised LDH (p = 0.003) and therapy requirement (p = 0.042) compared to patients with wild-type STAT3. The gene discussed is STAT3; the disease is neutropenia.